Resultados da pesquisa por Autor

1

Monitoring in vivo of transmitter metabolism by electrochemical methods.

Monitoring in vivo of transmitter metabolism by electrochemical methods.

Por Hutson, P H, Curzon, G
Publicado em 1983

Obter o texto integral
Obter o texto integral

Artigo

2

Concurrent determination of effects of p-chloroamphetamine on central extracellular 5-hydroxytryptamine concentration and behaviour.

Concurrent determination of effects of p-chloroamphetamine on central extracellular 5-hydroxytryptamine concentration and behaviour.

Por Hutson, P. H., Curzon, G.
Publicado em 1989

Obter o texto integral
Obter o texto integral

Artigo

3

Voltammetry in vivo: effect of stressful manipulations and drugs on the caudate nucleus of the rat [proceedings]

Voltammetry in vivo: effect of stressful manipulations and drugs on the caudate nucleus of the rat [proceedings]

Por Curzon, G., Hutson, P. H., Knott, P. J.
Publicado em 1979

Obter o texto integral
Obter o texto integral

Artigo

4

An in vivo dialysis and behavioural study of the release of 5-HT by p-chloroamphetamine in reserpine-treated rats.

An in vivo dialysis and behavioural study of the release of 5-HT by p-chloroamphetamine in reserpine-treated rats.

Por Adell, A., Sarna, G. S., Hutson, P. H., Curzon, G.
Publicado em 1989

Obter o texto integral
Obter o texto integral

Artigo

5

The glycine/NMDA receptor antagonist, R-(+)-HA-966, blocks activation of the mesolimbic dopaminergic system induced by phencyclidine and dizocilpine (MK-801) in rodents.

The glycine/NMDA receptor antagonist, R-(+)-HA-966, blocks activation of the mesolimbic dopaminergic system induced by phencyclidine and dizocilpine (MK-801) in rodents.

Por Bristow, L. J., Hutson, P. H., Thorn, L., Tricklebank, M. D.
Publicado em 1993

Obter o texto integral
Obter o texto integral

Artigo

6

R-(+)-HA-966, a glycine/NMDA receptor antagonist, selectively blocks the activation of the mesolimbic dopamine system by amphetamine.

R-(+)-HA-966, a glycine/NMDA receptor antagonist, selectively blocks the activation of the mesolimbic dopamine system by amphetamine.

Por Hutson, P. H., Bristow, L. J., Thorn, L., Tricklebank, M. D.
Publicado em 1991

Obter o texto integral
Obter o texto integral

Artigo

7

The anticonvulsant and behavioural profile of L-687,414, a partial agonist acting at the glycine modulatory site on the N-methyl-D-aspartate (NMDA) receptor complex.

Por Tricklebank, M D, Bristow, L J, Hutson, P H, Leeson, P D, Rowley, M, Saywell, K, Singh, L, Tattersall, F D, Thorn, L, Williams, B J
Publicado em 1994

Obter o texto integral
Obter o texto integral

Artigo

8

L-689,660, a novel cholinomimetic with functional selectivity for M1 and M3 muscarinic receptors.

L-689,660, a novel cholinomimetic with functional selectivity for M1 and M3 muscarinic receptors.

Por Hargreaves, R. J., McKnight, A. T., Scholey, K., Newberry, N. R., Street, L. J., Hutson, P. H., Semark, J. E., Harley, E. A., Patel, S., Freedman, S. B.
Publicado em 1992

Obter o texto integral
Obter o texto integral

Artigo

9

Enantiomers of HA-966 (3-amino-1-hydroxypyrrolid-2-one) exhibit distinct central nervous system effects: (+)-HA-966 is a selective glycine/N-methyl-D-aspartate receptor antagonist, but (-)-HA-966 is a potent gamma-butyrolactone-like sedative.

Enantiomers of HA-966 (3-amino-1-hydroxypyrrolid-2-one) exhibit distinct central nervous system effects: (+)-HA-966 is a selective glycine/N-methyl-D-aspartate receptor antagonist,...

Por Singh, L, Donald, A E, Foster, A C, Hutson, P H, Iversen, L L, Iversen, S D, Kemp, J A, Leeson, P D, Marshall, G R, Oles, R J
Publicado em 1990

Obter o texto integral
Obter o texto integral

Artigo